Genetics in glioma: Lessons learned from genome-wide association studies

Current Opinion in Neurology

Volumn 26, Issue 6, 2013, Pages 688-692

  Melin, Beatrice ^a   Jenkins, Robert ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b MAYO CLINIC   (United States)

Author keywords

Genotype; Glioblastoma; Glioma origin; Oligodendroglioma; Phenotype

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE 2; PROTEIN P53; TELOMERASE REVERSE TRANSCRIPTASE; VASCULOTROPIN RECEPTOR; TUMOR MARKER;

ALLELE; CANCER GENETICS; CANCER GROWTH; CANCER RISK; DISEASE SEVERITY; GENE CONTROL; GENE FREQUENCY; GENE LOCUS; GENE LOSS; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GLIOBLASTOMA; HUMAN; REVIEW; SEQUENCE ANALYSIS; TELOMERE; TUMOR GENE; BRAIN TUMOR; GENETIC PREDISPOSITION; GENETICS; GLIOMA;

BRAIN NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GLIOMA; HUMANS; TUMOR MARKERS, BIOLOGICAL;

EID: 84892371061     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0000000000000033     Document Type: Review

References (25)

1. Bondy ML, Scheurer ME, Malmer B, et al. Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium. Cancer 2008; 113 (7 Suppl):1953-1968.
2. Shete S, Hosking FJ, Robertson LB, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 2009; 41:899-954.
3. Wrensch M, Jenkins RB, Chang JS, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 2009; 41:905-908.
4. Stacey SN, Sulem P, Jonasdottir A, et al. A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet 2011; 43:1098-1185.
5. Andersson U, Schwartzbaum J, Wiklund F, et al. A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk. Acta Oncol 2010; 49:767-775.
6. Sanson M, Hosking FJ, Shete S, et al. Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum Mol Genet 2011; 20:2897-2904.
7. Rajaraman P, Melin BS, Wang ZM, et al. Genome-wide association study of glioma and meta-analysis. Hum Genet 2012; 131:1877-1888.
8. Melin B, Dahlin AM, Andersson U, et al. Known glioma risk loci are associated with glioma with a family history of brain tumours - A case-control gene association study. Int J Cancer 2013; 132:2464-2468.
9. TCGA group. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008; 455:1061-1068.
10. Killela PJ, Reitman ZJ, Jiao YC, et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci USA 2013; 110:6021-6026.
11. Huppi K, Pitt JJ, Wahlberg BM, et al. The 8q24 gene desert: An oasis of noncoding transcriptional activity. Front Genet 2012; 3:69.
12. Jenkins RB, Xiao YY, Sicotte H, et al. A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation. Nat Genet 2012; 44:1122-1130.
13. Enciso-Mora V, Hosking FJ, Kinnersley B, et al. Deciphering the 8q24.21 association for glioma. Hum Mol Genet 2013; 22:2293-2302.
14. Jenkins RB, Wrensch MR, Johnson D, et al. Distinct germ line polymorphisms underlie glioma morphologic heterogeneity. Cancer Genet 2011; 204:13-18.
15. Malmer B, Feychting M, Lonn S, et al. p53 genotypes and risk of glioma and meningioma. Cancer Epidemiol Biomarkers Prev 2005; 14:2220-2223.
16. Enciso-Mora V, Hosking FJ, Di Stefano AL, et al. Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222. Br J Cancer 2013; 108:2178-2185.
17. Bojesen SE, Pooley KA, Johnatty SE, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013; 45:371-384; 84e1-2.
18. Zhao Y, Chen G, Zhao Y, et al. Fine-mapping of a region of chromosome 5p15.33 (TERT-CLPTM1L) suggests a novel locus in TERT and a CLPTM1L haplotype are associated with glioma susceptibility in a Chinese population. Int J Cancer 2012; 131:1569-1576.
19. Melin BS, Nordfjall K, Andersson U, et al. hTERT cancer risk genotypes are associated with telomere length. Genet Epidemiol 2012; 36:368-372.
20. Walsh KM, Rice T, Decker PA, et al. Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis. Neuro Oncol 2013; 15:1041-1047.
21. Sottoriva A, Spiteri I, Piccirillo SGM, et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci USA 2013; 110:4009-4014
22. Wibom C, Ghasimi S, Van Loo P, et al. EGFR gene variants are associated with specific somatic aberrations in glioma. PLoS One 2012; 7:e47929.
23. Di Stefano AL, Enciso-Mora V, Marie Y, et al. Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies. Neuro Oncol 2013; 15:542-547.
24. Rice T, Zheng S, Decker PA, et al. Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology. Neuro Oncol 2013; 15:535-541.
25. Noushmehr H, Weisenberger DJ, Diefes K, et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 2010; 17:510-522